Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function (SEXUTOX)

Centre Oscar Lambret

Status: Completed

Conditions: Corpus Uteri Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT01650987

SEXUTOX

Details and patient eligibility

About

Evaluate the toxicities of cervix and corpus uteri carcinomas treatment

Full description

Evaluate the toxicities of cervix and corpus uteri carcinomas treatment on sexual function after treatment (radiotherapy and/or surgery)

Enrollment: 72 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Inclusion Criteria:
• Patients whose treatment is provided to Centre Oscar Lambret
• With a corpus uteri adenocarcinoma, no metastatic, treated by:
• Surgery and observation without complementary treatment
• Or surgery and adjuvant radiotherapy
• Or Surgery and curietherapy of vaginal dome
• With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
• External radiochemotherapy and curietherapy
• Or only surgery
• Or pre-surgical curietherapy and surgery
• Age > 18 years

Trial design

72 participants in 6 patient groups

Col 1

Description:

Patient with uterus adenocarcinoma, treated by surgery, then surveillance without complementary treatment

Col 2

Description:

Patient with uterus adenocarcinoma, treated by surgery then adjuvant radiotherapy

Col 3

Description:

patient with uterus adenocarcinoma, treated by surgery then curietherapy of vaginal dome

Endometrial 4

Description:

patient with cervix carcinoma stage IA2 to IIB, treated by surgery only

endometrial 5

Description:

patient with cervix carcinoma stage IA2 to IIB, treated by surgery then curietherapy

endometrial 6

Description:

patient with cervix carcinoma stage IA2 to IIB, treated by surgery then curietherapy and radiotherapy